Use of Natriuretic Peptide Assay in Dyspnea

被引：6
作者：
Christ, M. [1 ]
Mueller, C. [1 ]
机构：
[1] Univ Spital Basel, Med Klin A, Dept Innere Med, CH-4031 Basel, Switzerland
来源：
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2008年 / 105卷 / 06期
关键词：
natriuretic peptides; acute dyspnea; acute heart failure; diagnosis; prognosis;
D O I：
10.3238/arztebl.2008.0095
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Introduction: Acute dyspnea is a common symptom in patients admitted to hospital via emergency department. Heart failure is a common cause with high morbidity and mortality, but diagnostically challenging. Improvement in diagnostic techniques is needed. Methods: Selective search of Medline. Results: B-type natriuretic peptide (BNP) and its N-terminal fragment (NT-proBNP) are extremely helpful in the diagnosis of heart failure in patients with acute dyspnea. The use of natriuretic peptide assay has also been shown to be cost-effective. Since plasma levels of natriuretic peptides reflect the extent of systolic and diastolic dysfunction, measurement of natriuretic peptides is helpful in estimating overall risk in patients with heart failure or acute myocardial infarction. They have also been used in the management of patients with valvular disease and in tailoring therapy in patients with heart failure. Discussion: BNP and NT-proBNP are quantitative markers of heart failure that are helpful for diagnosis, prognosis and treatment monitoring. Dtsch Arztebl Int 2008; 105(6): 95-100 DOI: 10.3238/arztebl.2008.0095
引用
收藏
页码：95 / 100
页数：6
相关论文
共 25 条
[1]   B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [J].
Berger, R ;
Huelsman, M ;
Strecker, K ;
Bojic, A ;
Moser, P ;
Stanek, B ;
Pacher, R .
CIRCULATION, 2002, 105 (20) :2392-2397
[2]   Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea [J].
Christ, M. ;
Thuerlimann, A. ;
Laule, K. ;
Klima, T. ;
Hochholzer, W. ;
Perruchoud, A. P. ;
Mueller, C. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (11) :834-841
[3]  
CHRIST M, 2007, INT J CARDI IN PRESS
[4]   B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators [J].
Christ, Michael ;
Sharkova, Julia ;
Bayrakcioglu, Somer ;
Herzum, Ileana ;
Mueller, Christian ;
Grimm, Wolfram .
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (03) :272-279
[5]   Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea - Insights from the B-type natriuretic peptide for Acute Shortness of Breath Evaluation Study [J].
Christ, Michael ;
Laule-Kilian, Kirsten ;
Hochholzer, Willibald ;
Klima, Theresia ;
Breidthardt, Tobias ;
Perruchoud, Andre P. ;
Mueller, Christian .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (09) :1808-1812
[6]   B-type natriuretic peptide in cardiovascular disease [J].
de Lemos, JA ;
McGuire, DK ;
Drazner, MH .
LANCET, 2003, 362 (9380) :316-322
[7]   The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes [J].
de Lemos, JA ;
Morrow, DA ;
Bentley, JH ;
Omland, T ;
Sabatine, MS ;
McCabe, CH ;
Hall, C ;
Cannon, CP ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (14) :1014-1021
[8]   B-type natriuretic peptide in organic mitral regurgitation - Determinants and impact on outcome [J].
Detaint, D ;
Messika-Zeitoun, D ;
Avierinos, JF ;
Scott, C ;
Chen, H ;
Burnett, JC ;
Enriquez-Sarano, M .
CIRCULATION, 2005, 111 (18) :2391-2397
[9]   How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review [J].
Doust, JA ;
Pietrzak, E ;
Dobson, A ;
Glasziou, PP .
BRITISH MEDICAL JOURNAL, 2005, 330 (7492) :625-627
[10]   Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure [J].
Horwich, TB ;
Patel, J ;
MacLellan, WR ;
Fonarow, GC .
CIRCULATION, 2003, 108 (07) :833-838
123